mariPOC® test system
mariPOC® test system enables fast and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The fully automated test system enables central laboratory sensitivity and specificity in rapid and decentralized testing. The quality of the results is ensured by a unique internal autoverification system. These together with ease of use make mariPOC® perfectly suitable also for point-of-care testing (POCT).
News
Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe
Turku, September 10th 2020 – ArcDia International Oy Ltd (“ArcDia”), developer and manufacturer of the...
Press release: ArcDia Ltd’s automated coronavirus point-of-care test CE marked and available
Turku Finland, May 25, 2020 – the Finnish medical device manufacturer ArcDia International Ltd has...
Press Release: ArcDia Ltd reports a breakthrough in the development of an automated coronavirus point-of-care test
Turku Finland, April 27, 2020 – the Finnish medical device manufacturer ArcDia International Ltd reports...
Events
ECCMID 2019, Amsterdam, Netherlands
You are invited to visit booth 1.7f and meet mariPOC® team! At our booth you...
ECCMID 2018, Madrid, Spain
Welcome to experience our exciting mariPOC® booth #100 in ECCMID 2018, Madrid, Spain, April 21st...
Finnish Virology days
mariPOC is present in Finnish Virology days in Tuusula, Finland. Welcome to have a chat...
mariPOC’s Team Strength
The strength of the mariPOC team lies in our team members. At ArcDia, we believe that diversity enriches our ideas, discussions and leads to better results. Consequently, we are able to deliver better products to our customers. Watch how one of our international team members made her way to ArcDia from an Indian metropolitan city.